Company: OCEA
Filing Date: 2025-02-26
Form Type: 8-K
Source: 0001493152-25-008395
Chunk: 1

Company: Ocean Biomedical, Inc.
Filing Date: 2025-02-26
Form: 8-K
Item: Item 5.03
Chunk 1
---
 described above will be offered in a private placement under Section 4(a)(2) of the Securities Act of 1933,
as amended (the “ Act”), and Regulation D promulgated thereunder and, along with the shares of common stock underlying the
Series A preferred stock, have not been registered under the Act, or applicable state securities laws. Accordingly, the Series A preferred
stock and underlying shares of common stock may not be offered or sold in the United States except pursuant to an effective registration
statement or an applicable exemption from the registration requirements of the Act and such applicable state securities laws.

The
Series A preferred stock described above will be offered in a private placement under Section 4(a)(2) of the Securities Act of 1933,
as amended (the “ Act”), and Regulation D promulgated thereunder and, along with the shares of common stock underlying the
Series A preferred stock, have not been registered under the Act, or applicable state securities laws. Accordingly, the Series A preferred
stock and underlying shares of common stock may not be offered or sold in the United States except pursuant to an effective registration
statement or an applicable exemption from the registration requirements of the Act and such applicable state securities laws.

The
Series A preferred stock will only be utilized to vote on the reverse stock split. The Company is utilizing this “mirrored”
preferred stock (which will vote in favor of the reverse stock split in the same proportion as holders of common stock will vote in favor
of this measure), thus the super voting preferred will be voting accordance to the preference of the shareholders who do vote with respect
to this measure.

Item
9.01 Exhibits